Pharmacogenetics and olanzapine treatment: CYP1A2*1F and serotonergic polymorphisms influence therapeutic outcome.

Source:http://linkedlifedata.com/resource/pubmed/id/19636338

Download in:

View as

General Info

PMID
19636338